EMA Approves Biocon Biologics' New mAbs Facility in India and Renews GMP Certifications for India and Malaysia Sites

Contributed by: PR Newswire

Tags

EMA-Approves-Biocon

More Like This

WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

PR Newswire associated0

Biocon's Pertuzumab Becomes First Biosimilar to Secure EMA CHMP Approval Recommendation Under New Tailored Clinical Approach

PR Newswire associated0

Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates

PR Newswire associated0

Altruist Biologics' Suzhou Site Receives EMA GMP Certification, Enabling Product Commercialization for the European Market

WuXi Biologics Ireland Facility Receives EMA Approval for Commercial Manufacturing of Innovative Biologic

PR Newswire associated0

Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe

PR Newswire associated0

MS Pharma Establishes MENA's First Biologics Manufacturing Hub in Saudi Arabia, Advancing Regional Leadership and Global Partnerships

Thousand Oaks Biologics Shanghai ADC Site receives EU QP Declaration